Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003460018 | SCV004194587 | pathogenic | Wolcott-Rallison dysplasia | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003553950 | SCV004292620 | pathogenic | not provided | 2023-03-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with diabetes mellitus (PMID: 31638168). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg638*) in the EIF2AK3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EIF2AK3 are known to be pathogenic (PMID: 11997520). |